AB0407 IS THERE ANY DIFFERENCE BETWEEN SWITCHING AND CYCLING PATIENTS AFTER TUMOR NECROSIS FACTOR INHIBITOR (TNFi) FAILURE IN PSORIATIC ARTHRITIS? - CHARACTERIZATION OF A PORTUGUESE COHORT WITH ONE YEAR OF TREATMENT WITH TNFi AS THE FIRST BIOLOGICAL DMARDCatarina Gomes, Lúcia Costa, M. Bernardes et al.|Annals of the Rheumatic Diseases|2024Cited by 1
AB0666 CYCLING VERSUS SWITCHING AFTER INEFFECTIVENESS OF FIRST TUMOR NECROSIS FACTOR INHIBITOR DURING FIRST YEAR OF THERAPY - DEMOGRAPHIC AND CLINICAL DIFFERENCES IN RHEUMATOID ARTHRITISIsabel Kinney Ferreira de Miranda Santos, Lúcia Costa, M. Diz Lopes et al.|Annals of the Rheumatic Diseases|2024Cited by 0